You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天士力(600535.SH):公司药品拟中标国家药品集中采购
格隆汇 01-19 17:51

格隆汇1月19日丨天士力(600535.SH)公告,按照国家医保局、国家卫生健康委、国家药监局、工业和信息化部、中央军委后勤保障部《关于开展第二批国家组织药品集中采购和使用工作的通知》(医保发〔2020〕2号)要求,2020年1月17日,天士力医药集团股份有限公司(以下简称“公司”)参加了国家药品集中采购投标工作。

公司全资子公司江苏天士力帝益药业有限公司(以下简称“江苏天士力”)、控股子公司天津天士力(辽宁)制药有限责任公司(以下简称“辽宁天士力”)已通过国家药品监督管理局仿制药质量和疗效一致性评价的仿制药品他达拉非与吲达帕胺拟中标本次集中采购。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account